Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Performance of 13C Mannitol for Intestinal Permeability Measurement
NCT02603822Phase 1Completed
- Sponsor
- Mayo Clinic
- Start
- Aug 2015
- Primary completion
- Jul 2018
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Mayo Clinic. Primary endpoint: Small intestine permeability as measured by change in cumulative excretion of mannitol 0-2 hours. Started Aug 2015; status: completed.
Beyond the preview
Go deeper on NCT02603822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02603822.